Association Between Tissue No-Reflow and Prognosis After successful Recanalization in Endovascular Treatment of Intracranial Atherosclerotic Occlusion: A Post Hoc Subgroup Analysis of the ANGEL-REBOOT Trial
American Journal of Neuroradiology · 13.11.2026 · ajnr.A9717
DOI: 10.3174/ajnr.a9717 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Neuroradiology, online erschienen am 13.11.2026. Verfasst von Yingchun Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neurology (Y.W.), ORDOS Central Hospital, ORDOS 017000, China; Department of Interventional Neuroradiology (F.G., L.L., X.T.),….
Abstract (Originalsprache)
BACKGROUND: No-reflow after successful endovascular treatment (EVT) predicts poor outcomes in acute ischemic stroke (AIS) due to intracranial atherosclerotic stenosis (ICAS), but its optimal evaluation and prognostic value remain unclear. This study assessed computed tomography perfusion (CTP)-defined no-reflow for predicting outcomes in ICAS-related large vessel occlusion (ICAS-LVO). METHODS: This retrospective post hoc analysis included patients from the prospective ANGEL-REBOOT trial with anterior circulation ICAS-LVO, successful eTICI 2b/3 recanalization, and postoperative 24-hour CTP. No-reflow was defined as persistent hypoperfusion (Tmax >4s or >6s) after recanalization. Outcomes included 90-day modified Rankin Scale (mRS) score (poor outcome ≥3) and 24-hour National Institutes of Health Stroke Scale (NIHSS) score. RESULTS: In this exploratory post-hoc analysis, the optimal cohort derived cutoff value for Tmax > 4s hypoperfusion volume was 95.8 mL. Among 64 patients, Tmax >4s hypoperfusion volume ≥95.8 mL best predicted poor 90-day outcome (area under the curve [AUC] 0.75). Larger Tmax >4s volumes correlated with worse 90-day mRS scores (P=0.04) and higher 24-hour NIHSS scores (P=0.006). Tmax >6s (cutoff 9.9 mL, AUC 0.690) only predicted higher 24-hour NIHSS score (P=0.001) but not 90-day outcomes (P=0.12). CONCLUSIONS: Postoperative 24-hour CTP Tmax > 4 s hypoperfusion volume showed a trend toward better prediction of 90-day poor functional outcomes compared with Tmax > 6 s in recanalized ICAS-LVO patients.
Autor:innen und Institutionen
- From the Department of Neurology (Y.W.), ORDOS Central Hospital, ORDOS 017000, China; Department of Interventional Neuroradiology (F.G., L.L., X.T.), Beijing Tiantan Hospital, Capital Medical University, Beijing 100050,…
Zitieren
APA
Wu, Y., Gao, F., Li, L., Tong, X., Xu, B., Xu, C., & ANGEL-REBOOT Study Group (2026). Association Between Tissue No-Reflow and Prognosis After successful Recanalization in Endovascular Treatment of Intracranial Atherosclerotic Occlusion: A Post Hoc Subgroup Analysis of the ANGEL-REBOOT Trial. American Journal of Neuroradiology, ajnr.A9717. https://doi.org/10.3174/ajnr.a9717
Vancouver
Wu Y, Gao F, Li L, Tong X, Xu B, Xu C, et al. Association Between Tissue No-Reflow and Prognosis After successful Recanalization in Endovascular Treatment of Intracranial Atherosclerotic Occlusion: A Post Hoc Subgroup Analysis of the ANGEL-REBOOT Trial. American Journal of Neuroradiology. 2026:ajnr.A9717. doi:10.3174/ajnr.a9717
BibTeX
@article{Wu2026,
author = {Wu, Yingchun and Gao, Feng and Li, Lei and Tong, Xu and Xu, Bo and Xu, Chenghua and ANGEL-REBOOT Study Group, ANGEL-REBOOT Study Group},
title = {Association Between Tissue No-Reflow and Prognosis After successful Recanalization in Endovascular Treatment of Intracranial Atherosclerotic Occlusion: A Post Hoc Subgroup Analysis of the ANGEL-REBOOT Trial},
journal = {American Journal of Neuroradiology},
year = {2026},
pages = {ajnr.A9717},
doi = {10.3174/ajnr.a9717}
}
EUVIMED